1. |
Korniluk A, Koper-Lenkiewicz OM, Kamińska J, et al. Mean platelet volume (MPV): new perspectives for an old marker in the course and prognosis of inflammatory conditions[J/OL]. Mediators Inflamm, 2019, 2019: 9213074[2019-04-17]. https://pubmed.ncbi.nlm.nih.gov/31148950/. DOI: 10.1155/2019/9213074.
|
2. |
Zhou Z, Chen H, Ju H, et al. Platelet indices in patients with chronic inflammatory arthritis: a systematic review and meta-analysis[J]. Platelets, 2020, 31(7): 834-844. DOI: 10.1080/09537104.2019.1704714.
|
3. |
Gasparyan AY, Ayvazyan L, Mukanova U, et al. The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases[J]. Ann Lab Med, 2019, 39(4): 345-357. DOI: 10.3343/alm.2019.39.4.345.
|
4. |
Buonacera A, Stancanelli B, Colaci M, et al. Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases[J]. Int J Mol Sci, 2022, 23(7): 3636. DOI: 10.3390/ijms23073636.
|
5. |
Vizioli L, Muscari S, Muscari A. The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases[J]. Int J Clin Pract, 2009, 63(10): 1509-1515. DOI: 10.1111/j.1742-1241.2009.02070.x.
|
6. |
Aref SF, Jalal AM, Mawlood ZK, et al. Plateletcrit is a useful marker in the quality of life assessment of patients with rheumatoid arthritis: a cross-sectional study from Erbil, Iraq[J]. Saudi J Med Med Sci, 2023, 11(2): 150-156. DOI: 10.4103/sjmms.sjmms_ 517_22.
|
7. |
Beyazit Y, Sayilir A, Torun S, et al. Mean platelet volume as an indicator of disease severity in patients with acute pancreatitis[J]. Clin Res Hepatol Gastroenterol, 2012, 36(2): 162-168. DOI: 10.1016/j.clinre.2011.10.003.
|
8. |
Mertoglu C, Gunay M. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as useful predictive markers of prediabetes and diabetes mellitus[J]. Diabetes Metab Syndr, 2017, 11(Suppl 1): S127-131. DOI: 10.1016/j.dsx.2016.12.021.
|
9. |
Serban D, Papanas N, Dascalu AM, et al. Significance of neutrophil to lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) in diabetic foot ulcer and potential new therapeutic targets[J/OL]. Int J Low Extrem Wounds, 2021: 15347346211057742[2021-11-18]. https://pubmed.ncbi.nlm.nih.gov/34791913/. DOI: 10.1177/15347346211057742.
|
10. |
Gao F, Chen C, Hu L, et al. Rationale, design and methodology of a population-based ocular study in a suburbanization region in Tianjin, China: The Beichen Eye Study[J/OL]. OphthalmicEpidemiol, 2023, 30: 1-10[2023-06-30]. https://pubmed.ncbi.nlm.nih.gov/37387482/. DOI: 10.1080/09286586.2023.2225582.
|
11. |
Wilkinson CP, Ferris FL, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales[J]. Ophthalmology, 2003, 110(9): 1677-1682. DOI: 10.1016/S0161-6420(03)00475-5.
|
12. |
Kern TS. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy[J/OL]. Exp Diabetes Res, 2007, 2007: 95103[2007-10-01]. https://pubmed.ncbi.nlm.nih.gov/18274606/. DOI: 10.1155/2007/95103.
|
13. |
Portillo JC, Yu JS, Vos S, et al. Disruption of retinal inflammation and the development of diabetic retinopathy in mice by a CD40-derived peptide or mutation of CD40 in Müller cells[J]. Diabetologia, 2022, 65(12): 2157-2171. DOI: 10.1007/s00125-022-05775-6.
|
14. |
Deliyanti D, Zhang Y, Khong F, et al. FT011, a novel cardiorenal protective drug, reduces inflammation, gliosis and vascular injury in rats with diabetic retinopathy[J/OL]. PLoS One, 2015, 10(7): e0134392[2015-07-29]. https://pubmed.ncbi.nlm.nih.gov/26222724/. DOI: 10.1371/journal.pone.0134392.
|
15. |
Ayhan Tuzcu E, Arıca S, Ilhan N, et al. Relationship between mean platelet volume and retinopathy in patients with type 2 diabetes mellitus[J]. Graefe's Arch Clin Exp Ophthalmol, 2014, 252(2): 237-240. DOI: 10.1007/s00417-013-2444-y.
|
16. |
Buch A, Kaur S, Nair R, et al. Platelet volume indices as predictive biomarkers for diabetic complications in type 2 diabetic patients[J]. J Lab Physicians, 2017, 9(2): 84-88. DOI: 10.4103/0974-2727.199625.
|
17. |
Yilmaz T, Yilmaz A. Relationship between altered platelet morphological parameters and retinopathy in patients with type 2 diabetes mellitus[J/OL]. J Ophthalmol, 2016, 2016: 9213623[2016-04-12]. https://pubmed.ncbi.nlm.nih.gov/27190641/. DOI: 10.1155/2016/9213623.
|
18. |
Kucuk I, Tural E, Doğantekin B, et al. Evaluation of platelet indices and pro-inflammatory cytokines in type 2 diabetic patients with retinopathy[J]. Rev Assoc Med Bras (1992), 2022, 68(11): 1537-1541. DOI: 10.1590/1806-9282.20220479.
|
19. |
Tong PC, Lee KF, So WY, et al. White blood cell count is associated with macro-and microvascular complications in chinese patients with type 2 diabetes[J]. Diabetes Care, 2004, 27(1): 216-222. DOI: 10.2337/diacare.27.1.216.
|
20. |
Woo SJ, Ahn SJ, Ahn J, et al. Elevated systemic neutrophil count in diabetic retinopathy and diabetes: a hospital-based cross-sectional study of 30, 793 Korean subjects[J]. Invest Ophthalmol Vis Sci, 2011, 52(10): 7697-7703. DOI: 10.1167/iovs.11-7784.
|
21. |
Vidal AC, Howard LE, de Hoedt A, et al. Neutrophil, lymphocyte and platelet counts, and risk of prostate cancer outcomes in white and black men: results from the SEARCH database[J]. Cancer Causes Control, 2018, 29(6): 581-588. DOI: 10.1007/s10552-018-1031-2.
|
22. |
Liu CC, Ko HJ, Liu WS, et al. Neutrophil-to-lymphocyte ratio as a predictive marker of metabolic syndrome[J/OL]. Medicine (Baltimore), 2019, 98(43): e17537[2019-10-01]. https://pubmed.ncbi.nlm.nih.gov/31651856/. DOI: 10.1097/MD.0000000000017537.
|
23. |
He X, Qi S, Zhang X, et al. The relationship between the neutrophil-to-lymphocyte ratio and diabetic retinopathy in adults from the United States: results from the national health and nutrition examination survey[J]. BMC Ophthalmol, 2022, 22(1): 346. DOI: 10.1186/s12886-022-02571-z.
|
24. |
Öztürk ZA, Kuyumcu ME, Yesil Y, et al. Is there a link between neutrophil-lymphocyte ratio and microvascular complications in geriatric diabetic patients?[J]. J Endocrinol Invest, 2013, 36(8): 593-599. DOI: 10.3275/8894.
|
25. |
Rajendrakumar AL, Hapca SM, Nair ATN, et al. Competing risks analysis for neutrophil to lymphocyte ratio as a predictor of diabetic retinopathy incidence in the Scottish population[J]. BMC Med, 2023, 21(1): 304. DOI: 10.1186/s12916-023-02976-7.
|
26. |
Wang JR, Chen Z, Yang K, et al. Association between neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and diabetic retinopathy among diabetic patients without a related family history[J]. Diabetol Metab Syndr, 2020, 12: 55. DOI: 10.1186/s13098-020-00562-y.
|
27. |
Zeng J, Chen M, Feng Q, et al. The platelet-to-lymphocyte ratio predicts diabetic retinopathy in type 2 diabetes mellitus[J]. Diabetes Metab Syndr Obes, 2022, 15: 3617-3626. DOI: 10.2147/DMSO.S378284.
|